OPK

OPK

USD

OPKO Health Inc. Common Stock

$1.410+0.040 (2.920%)

السعر في الوقت الحقيقي

Healthcare
Diagnostics & Research
الولايات المتحدة

مخطط الأسعار

Loading Chart...

المقاييس الرئيسية

مقاييس السوق
أساسيات الشركة
إحصاءات التداول

مقاييس السوق

الافتتاح

$1.370

الأعلى

$1.430

الأدنى

$1.370

الحجم

2.69M

أساسيات الشركة

القيمة السوقية

1.1B

الصناعة

Diagnostics & Research

البلد

United States

إحصاءات التداول

متوسط الحجم

2.21M

البورصة

NMS

العملة

USD

نطاق 52 أسبوعاً

الأدنى $1.11الحالي $1.410الأعلى $2.04

أخبار ذات صلة

Analyst Upgrades

Jefferies Downgrades OPKO Health to Hold, Lowers Price Target to $1.6

Jefferies analyst Maury Raycroft downgrades OPKO Health from Buy to Hold and lowers the price target from $2 to $1.6.

عرض المزيد
Jefferies Downgrades OPKO Health to Hold, Lowers Price Target to $1.6
Analyst Upgrades

Barrington Research Maintains Outperform on OPKO Health, Maintains $2.25 Price Target

Barrington Research analyst Michael Petusky maintains OPKO Health with a Outperform and maintains $2.25 price target.

عرض المزيد
Barrington Research Maintains Outperform on OPKO Health, Maintains $2.25 Price Target
GlobeNewswire

OPKO Health's ModeX Therapeutics Enters into Research Collaboration with Regeneron to Develop Multispecific Antibodies for Select Therapeutic Indications

Potential assets would target multiple biological pathways in a single molecule Total value of the partnership potentially exceeds $1 billion if multiple assets advance WESTON, Mass., Oct. 29, 2025 (GLOBE NEWSWIRE) --

عرض المزيد
OPKO Health's ModeX Therapeutics Enters into Research Collaboration with Regeneron to Develop Multispecific Antibodies for Select Therapeutic Indications
GlobeNewswire

OPKO Health's ModeX Therapeutics Begins Clinical Trial of MDX2004 for the Treatment of Advanced Cancers

First patient dosed in Phase 1/2a study with novel immune rejuvenator, a trispecific antibody-fusion protein Two MDX2004 abstracts accepted for poster presentation at SITC Annual Meeting 2025 WESTON, Mass., Oct. 28,

عرض المزيد
OPKO Health's ModeX Therapeutics Begins Clinical Trial of MDX2004 for the Treatment of Advanced Cancers
GlobeNewswire

OPKO Health to Report Third Quarter 2025 Financial Results on October 29

MIAMI, Oct. 22, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ:OPK) plans to report operating and financial results for the three and nine months ended September 30, 2025 after the close of the U.S. financial

عرض المزيد
OPKO Health to Report Third Quarter 2025 Financial Results on October 29

ابق على اطلاع

تعيين تنبيهات الأسعار، الحصول على تحديثات تحليل الذكاء الاصطناعي وأخبار السوق في الوقت الحقيقي.